Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Increasing mir-302 turns human hair cells into stem cells by changing gene regulation and demethylation.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Spironolactone treatment increases the amount of testosterone available in the body.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Skin fat cells help with skin balance, hair growth, and healing wounds.

A new microneedle patch made from hair proteins helps regrow hair faster and better than current treatments.

Fibromodulin might help reduce scarring if increased in adult wounds like in fetal skin that heals without scars.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Modulating BMP activity changes the number, size, shape, and type of ectodermal organs.

Finasteride may help some male chronic pelvic pain patients, but more research needed.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Hair grows faster in the morning and is more vulnerable to damage from radiation due to the internal clock in hair follicle cells.

Fetal wound healing changes with development, affecting inflammation and collagen, which may influence scarring.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

PRP shows potential for treating female hair loss, but more research needed.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

The hair follicle is a great model for research to improve hair growth treatments.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Blocking a specific protein signal can make hair grow on mouse nipples.